The introduction of electronic prescriptions has improved patient accessibility to medication and reduced the administrative burden on pharmacies related to faxed or emailed prescriptions. Most
Meridian Lawyers has collaborated with PDL to prepare an article about professional boundaries and the types of conduct that are likely to be the subject
Off-label prescribing occurs when a medication is used for a purpose that is not approved by the Australian Therapeutic Goods Administration (TGA). It may involve
In recent weeks, the PDL Professional Officers have received a number of queries regarding pharmacists’ obligations and liability when dispensing Mounjaro® (tirzepatide). Tirzepatide is a
PDL Professional Officers occasionally receive incident reports and notifications relating to breaches or concerns regarding access to a patient’s My Health Record. Some of these
PDL would like to bring the upcoming changes to SafeScript to the attention of Victorian pharmacists. Effective from 3 July 2023, pregabalin, gabapentin and tramadol
Pharmacists are in a unique position of trust. That trust requires pharmacists to respect and protect the privacy of those under their care. Patient information
PDL representatives Gilbert Yeates (Qld Director) and Gary West (Professional Officer and Qld Local Advisory Committee Chair) were pleased to attend ConPharm 2022 at Sea
PDL employs four pharmacist Professional Officers who are available 24/7 for PDL members. From the thousands of calls and emails received every year by the
Advice for health practitioners and organisations It is trite advice to Australian health practitioners to say that they must exercise caution when dealing with their